Jun 18 |
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine
|
Jun 18 |
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
|
Jun 18 |
Moment Of Truth Approaches For Moderna's RSV Vaccine
|
Jun 17 |
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
|
Jun 16 |
Moderna Just Gave Investors Another Reason to Buy the Stock
|
Jun 15 |
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
|
Jun 14 |
CDC 'preparing for the possibility' bird flu could spread more easily
|
Jun 14 |
Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the past week
|
Jun 14 |
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
|
Jun 13 |
FDA recommends KP.2 strain be used in updated COVID-19 shots
|